Compound for androgen receptor degradation, and pharmaceutical use thereof
US-2024383877-A1 · Nov 21, 2024 · US
Composition for preventing or treating keloid
US12064441B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12064441-B2 |
| Application number | US-202217818378-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 9, 2022 |
| Priority date | Aug 10, 2021 |
| Publication date | Aug 20, 2024 |
| Grant date | Aug 20, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are a composition for treating or preventing recurrence of keloid comprising tauroursodeoxycholic acid as an active ingredient, and a method for treating keloid or preventing recurrence of keloid using the composition.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for improving keloids or preventing recurrence of keloids comprising administering to a subject in need thereof a composition comprising tauroursodeoxycholic acid as active ingredient, and thereby improving keloids or preventing recurrence of keloids in the subject. 2. The method according to claim 1 , wherein the composition comprising the tauroursodeoxycholic acid is injected into the dermis. 3. The method according to claim 1 , comprising an additional component or method effective for the treatment of keloids or scars. 4. The method according to claim 3 , wherein the additional component or method comprises at least one selected from the group consisting of an anti-inflammatory agent, an anti-fibrotic agent, a laser, and surgery. 5. The method according to claim 1 , wherein the composition is in the form of an external preparation for skin or injection.
Assignees
Inventors
Classifications
containing sulfonic acid derivatives; Salts · CPC title
Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title
- A61P17/02Primary
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Intradermal administration, e.g. through microneedle arrays or needleless injectors · CPC title
Preparations for care of the skin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12064441B2 cover?
- Provided are a composition for treating or preventing recurrence of keloid comprising tauroursodeoxycholic acid as an active ingredient, and a method for treating keloid or preventing recurrence of keloid using the composition.
- Who is the assignee on this patent?
- Chungnam National Univ Hospital, Iac In Nat Univ Chungnam
- What technology area does this patent fall under?
- Primary CPC classification A61P17/02. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).